Four Potential COVID-19 Therapeutics Enter Phase 2/3 Testing in NIH ACTIV-2 Trial
[ad_1] Press release Friday 12 February 2021 Registrations have started testing additional investigational drugs under the COVID-19 Accelerated Therapeutic Interventions and Vaccines (ACTIV) program. ACTIV is a public-private partnership program aimed at creating a coordinated research strategy that prioritizes and accelerates the development of promising COVID-19 treatments and vaccines. The new agents entering the randomized, … Read more